Shopping Cart
- Remove All
Your shopping cart is currently empty
APG-1387 (SM-1387) is an IAP inhibitor that promotes the rapid degradation of cIAP1/2 and XIAP and exerts an anti-tumor effect on nasopharyngeal carcinoma stem cells. Studies have shown that APG-1387 combined with NPC's CDDP and 5-FU enhance chemoresensitivity and promote cell apoptosis in vitro and in vivo.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $1,610 | Backorder | |
| 10 mg | $2,690 | Backorder |
| Description | APG-1387 (SM-1387) is an IAP inhibitor that promotes the rapid degradation of cIAP1/2 and XIAP and exerts an anti-tumor effect on nasopharyngeal carcinoma stem cells. Studies have shown that APG-1387 combined with NPC's CDDP and 5-FU enhance chemoresensitivity and promote cell apoptosis in vitro and in vivo. |
| Synonyms | SM-1387, SM1387, SM 1387, APG 1387l |
| Molecular Weight | 1157.41 |
| Formula | C60H72N10O10S2 |
| Cas No. | 1570231-89-8 |
| Relative Density. | 1.40 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.